Lopez, Felipe L.
Mistry, Punam
Batchelor, Hannah K.
Bennett, Joanne
Coupe, Alastair
Ernest, Terry B.
Orlu, Mine
Tuleu, Catherine
Article History
Received: 28 February 2018
Accepted: 29 May 2018
First Online: 15 June 2018
Competing Interests
: This work was supported by the CDT in Targeted Therapeutics and Formulation Sciences, which is funded by the EPSRC (EP/I01375X/1); and SPaeDD-UK (Accelerating Paediatric Formulation Development through Smart Design and Predictive Science), an Innovate UK Formulated Products Collaborative R&D project (Ref: 101709), which is co-funded by Innovate UK and the contributing companies of AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Juniper Pharma Services and Pfizer. The authors declare no financial and/or non-financial conflict of interest other than their disclosed affiliations and acknowledged funding.